Literature DB >> 7415753

Effect of carbohydrate restriction on lipoprotein abnormalities in maturity-onset diabetes mellitus.

J E Thomson, I N Scobie, F Ballantyne, A Smith, W G Manderson, A C MacCuish.   

Abstract

Hyperlipoproteinemia occurs commonly in diabetics and may contribute to early atherosclerosis in these patients. The effect of dietary carbohydrate restriction on lipid abnormalities has been examined in 42 newly diagnosed maturity-onset diabetics, in whom plasma lipoproteins were measured before treatment was started and at regular intervals during ten months of dietary therapy. Twenty-four patients (57%) had abnormal lipids when diabetes was first diagnosed. Nine were classed as Type II and 15 as Type IV hyperlipoproteinemia. Plasma lipids reverted to normal in half these patients after dietary treatment for one month. Only 8 diabetics (19%) showed persistent lipid abnormality after ten months' treatment: all had been unable to diet satisfactorily as judged by persisting obesity and hyperglycemia. The common lipoprotein abnormalities of maturity-onset diabetes can usually be returned to normal by the simplest possible carbohydrate-restricted diet, if patients adhere to this. Specialized and complex diets or lipid-lowering drugs are unncessary in the majority of patients.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7415753     DOI: 10.1007/bf02582075

Source DB:  PubMed          Journal:  Acta Diabetol Lat        ISSN: 0001-5563


  18 in total

1.  The prolonged effects of a low cholesterol, high carbohydrate diet upon the serum lipids in diabetic patients.

Authors:  D B STONE; W E CONNOR
Journal:  Diabetes       Date:  1963 Mar-Apr       Impact factor: 9.461

2.  Acute effect of dietary therapy of type IV hyperlipoproteinaemia on the serum and lipoprotein concentrations and relative composition.

Authors:  D Ballantyne; A G Olsson; L A Carlson
Journal:  Atherosclerosis       Date:  1978-05       Impact factor: 5.162

Review 3.  Classification of hyperlipidaemias and hyperlipoproteinaemias.

Authors:  J L Beaumont; L A Carlson; G R Cooper; Z Fejfar; D S Fredrickson; T Strasser
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

4.  Plasma lipoproteins in adult diabetes.

Authors:  T M Hayes
Journal:  Clin Endocrinol (Oxf)       Date:  1972-07       Impact factor: 3.478

5.  Atherosclerosis in diabetes mellitus. Correlations with serum lipid levels, adiposity, and serum insulin level.

Authors:  R J Santen; P W Willis; S S Fajans
Journal:  Arch Intern Med       Date:  1972-12

6.  An automated method for the direct determination of total serum cholesterol.

Authors:  W Annan; D M Isherwood
Journal:  J Med Lab Technol       Date:  1969-07

Review 7.  Fat transport in lipoproteins--an integrated approach to mechanisms and disorders.

Authors:  D S Fredrickson; R I Levy; R S Lees
Journal:  N Engl J Med       Date:  1967-01-19       Impact factor: 91.245

8.  Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease.

Authors:  G J Miller; N E Miller
Journal:  Lancet       Date:  1975-01-04       Impact factor: 79.321

9.  High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study.

Authors:  T Gordon; W P Castelli; M C Hjortland; W B Kannel; T R Dawber
Journal:  Am J Med       Date:  1977-05       Impact factor: 4.965

10.  Dietary intake and hyperlipidemia in controlled diabetic outpatients.

Authors:  Y Maruhama; R Abe; F Okuguchi; A Ohneda
Journal:  Diabetes       Date:  1977-02       Impact factor: 9.461

View more
  1 in total

Review 1.  Type 2 Diabetes Remission and Lifestyle Medicine: A Position Statement From the American College of Lifestyle Medicine.

Authors:  John Kelly; Micaela Karlsen; Gregory Steinke
Journal:  Am J Lifestyle Med       Date:  2020-06-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.